Pivotal Clinical Trial to Evaluate the Efficacy and Safety After NPNP-001 Application in Patients with Knee Osteoarthritis.

PHASE3Enrolling by invitationINTERVENTIONAL

Enrollment

260

Participants

Timeline

Start Date

January 8, 2025

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2026

Conditions

Knee Osteoarthritis

Interventions

DEVICE

NPNP-001

Description: NPNP-001 2ml per injection, once a week for 3 injections. Placebo(saline) 2ml per injection, once a week for 2 injections.

DEVICE

Conjuran

Description: Conjuran 2ml per injection, once a week for 5 injections.

Trial Locations (1)

Seoul ST. Mary's Hospital, Seoul